Literature DB >> 6207425

Monoclonal antibody analysis of diphtheria toxin--I. Localization of epitopes and neutralization of cytotoxicity.

D R Zucker, J R Murphy.   

Abstract

Forty-three hybridoma cell lines producing monoclonal antibody to diphtheria toxin were isolated. Based upon their reactivity with various fragments of the toxin and mutant toxin-related proteins, the monoclonal antibodies were subdivided into 10 groups which recognize at least 10 distinct epitopes on the toxin molecule. Specific antibodies directed against both fragments A and B were found to neutralize cytotoxicity, both in vitro and in vivo. Neutralization was found to correlate with antibody-mediated inhibition of toxin binding to its eukaryotic cell surface receptor. The results presented suggest that the Pro378 and/or Gly431 of mature toxin are part of, or close to, the toxin receptor-binding domain. In addition, antigenic determinants in the C-terminal portion of fragment A, as well as a portion of the toxin defined by the tox-3 and tox-45 nonsense mutations (i.e. ca 31,000-42,000 daltons) appear to be juxtaposed to the receptor-binding domain and may form a secondary binding region.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207425     DOI: 10.1016/0161-5890(84)90165-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.

Authors:  N Orr; J E Galen; M M Levine
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes.

Authors:  B Autran; F Triebel; M Viguier; M Jolivet; P Falmagne; P Debre
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

3.  Structure-function analyses of diphtheria toxin by use of monoclonal antibodies.

Authors:  J M Rolf; L Eidels
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

4.  Expression and immunological properties of the five subunits of pertussis toxin.

Authors:  A Nicosia; A Bartoloni; M Perugini; R Rappuoli
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

Review 5.  Protein Structure Facilitates High-Resolution Immunological Mapping.

Authors:  Madison Zuverink; Joseph T Barbieri
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

6.  Pharmacokinetics of the recombinant fusion protein DAB486IL-2 in animal models.

Authors:  P Bacha; S Forte; N Kassam; J Thomas; D Akiyoshi; C Waters; J Nichols; M Rosenblum
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Recombinant Staphylococcus strains as live vectors for the induction of neutralizing anti-diphtheria toxin antisera.

Authors:  C Fromen-Romano; P Drevet; A Robert; A Ménez; M Léonetti
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Diphtheria toxin-related cytokine fusion proteins: elongation factor 2 as a target for the treatment of neoplastic disease.

Authors:  J vanderSpek; L Cosenza; T Woodworth; J C Nichols; J R Murphy
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

9.  Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.

Authors:  V E Kelley; P Bacha; O Pankewycz; J C Nichols; J R Murphy; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.

Authors:  J T Barbieri; D Armellini; J Molkentin; R Rappuoli
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.